The little-explored therapeutic potential of nanoformulations of 1,25-dihydroxyvitamin D3 and its active analogs in prevalent inflammatory and oxidative disorders
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Nanomedicine (London, England) - 16(2021), 26 vom: 20. Nov., Seite 2327-2330 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Martín Giménez, Virna Margarita [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 16.11.2021 Date Revised 16.11.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2217/nnm-2021-0284 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM331519658 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM331519658 | ||
| 003 | DE-627 | ||
| 005 | 20231225213640.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/nnm-2021-0284 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1105.xml |
| 035 | |a (DE-627)NLM331519658 | ||
| 035 | |a (NLM)34610750 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Martín Giménez, Virna Margarita |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The little-explored therapeutic potential of nanoformulations of 1,25-dihydroxyvitamin D3 and its active analogs in prevalent inflammatory and oxidative disorders |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.11.2021 | ||
| 500 | |a Date Revised 16.11.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a 1,25-dihydroxyvitamin D3 | |
| 650 | 4 | |a anti-inflammatory | |
| 650 | 4 | |a antioxidative | |
| 650 | 4 | |a calcitriol | |
| 650 | 4 | |a cholecalciferol | |
| 650 | 4 | |a drug delivery | |
| 650 | 4 | |a nanocarriers | |
| 650 | 4 | |a nanoencapsulation | |
| 650 | 4 | |a nanoformulations | |
| 650 | 7 | |a Vitamin D |2 NLM | |
| 650 | 7 | |a 1406-16-2 |2 NLM | |
| 650 | 7 | |a 1,25-dihydroxyvitamin D |2 NLM | |
| 650 | 7 | |a 66772-14-3 |2 NLM | |
| 700 | 1 | |a Lahore, Henry |e verfasserin |4 aut | |
| 700 | 1 | |a Ferder, León |e verfasserin |4 aut | |
| 700 | 1 | |a Holick, Michael F |e verfasserin |4 aut | |
| 700 | 1 | |a Manucha, Walter |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nanomedicine (London, England) |d 2006 |g 16(2021), 26 vom: 20. Nov., Seite 2327-2330 |w (DE-627)NLM17228452X |x 1748-6963 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2021 |g number:26 |g day:20 |g month:11 |g pages:2327-2330 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2217/nnm-2021-0284 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2021 |e 26 |b 20 |c 11 |h 2327-2330 | ||